The United States has penned an agreement with drug-maker Moderna Inc. to acquire 100 million doses of its potential COVID-19 vaccine, U.S. president Donald Trump said in a press conference on Tuesday. The U.S. has made several deals to acquire doses of potential COVID-19 vaccines in advance of their approval by regulators, part of its Operation Warp Speed program that aims to deliver a vaccine in the U.S. by the end of 2020.
Health
Coronavirus: Trump says U.S. inks agreement with Moderna for 100M doses of COVID-19 vaccine candidate
More Videos
-
Ontario ends COVID-19 wastewater surveillance program
-
NACI announces changes to the flu vaccine after strain disappears
-
Paris 2024: Men’s triathlon postponed over Seine water quality
-
Canada’s first robot-assisted kidney transplant performed in Edmonton
-
University of Waterloo researchers estimate peak age for Olympic track and field athletes
-
Health Matters: Health Canada recalling various multivitamins and supplements
You are viewing an Accelerated Mobile Webpage.
View Original Article